Human Pathology
Publisher: Elsevier · ISSN 0046-8177 · 58 articles
- Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions
- Clinical impact of second opinion consultation in bladder biopsies and transurethral resection of bladder tumors
- TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms
- Single-section assessment of DNA mismatch repair using PMS2/MSH6 double immunohistochemistry
- Metastatic pancreatic acinar cell carcinoma to the liver mimicking neuroendocrine tumor (NET) and pancreatic ductal adenocarcinoma (PDAC): A series of seven cases
- Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+/HER2− breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score
- Non-small cell lung carcinomas with diffuse co-expression of TTF-1 and p40: Clinicopathologic and molecular characterization of a rare phenotype
- Pathologic characterization of non-mass enhancement lesions of the breast in MRI-guided biopsy
- SMARCA4-altered malignancies: Cytologic diagnostic challenges and clinicopathologic correlation
- Nonconventional colorectal dysplasia is less prevalent and has a more limited morphologic spectrum in patients without inflammatory bowel disease
- Histologic patterns of metastatic lymph nodes and recurrence patterns in resected pN1–2 lung adenocarcinoma
- Duct Quest: An international survey of genitourinary and community pathologists reveals diagnostic uncertainties in separating atypical intraductal proliferation from high-grade prostatic intraepithelial neoplasia and intraductal carcinoma of the prostate
- HER2 status in extrahepatic cholangiocarcinoma and gallbladder carcinoma: Concordance between immunohistochemistry and chromogenic in situ hybridization in 140 Cases
- Neuroendocrine cell proliferation in gastric and gastroesophageal carcinomas following neoadjuvant therapy: Frequency and association with clinicopathological parameters and prognosis
- The evolving landscape of pathologic interpretation in metabolic dysfunction-associated steatotic liver disease
- Real-world HER2 testing practices and performance of HER2 immunohistochemistry in non-breast, non-gastroesophageal solid tumors: Experience at a large U.S. academic institution
- Fusion partner dependent immunophenotype, chromoanagenesis, and prognosis in MEF2D-rearranged B-lymphoblastic leukemia
- Do clinical and pathologic differences exist between hepatic cavernous hemangiomas diagnosed radiologically versus those biopsied due to unclear clinical diagnosis?
- p16 expression in genital chronic graft-versus-host disease: A potential diagnostic pitfall
- Prognostic significance and interobserver reproducibility of tumor budding and poorly differentiated clusters in primary duodenal adenocarcinoma
- Unusual morphologic variants of solitary fibrous tumor: A case series of 17 cases featuring 10 distinct histomorphologies
- Clinicopathologic characteristics of gastric adenocarcinoma in autoimmune gastritis: Impact of Helicobacter pylori infection and diagnostic implications of multifocal disease
- Quantification of perineural invasion (PNI) in individual biopsy sites enhances postoperative risk stratification in prostate cancer: Comparison of unifocal and multifocal PNI within a single biopsy site
- Methylome profiling of uterine mesenchymal tumors identifies histologic mimics and reveals epigenetic heterogeneity among smooth muscle tumors classified as STUMP
- CSF3R-Mutated Non-AML Myeloid Neoplasms as a Potential Distinct Disease Entity: A 40-Case Study
- Infarcted tenosynovial giant cell tumors: Multi-institutional analysis of 80 cases highlighting consultation patterns and diagnostic challenges
- BAP1 loss and TFE3 immunoexpression in high-grade clear cell renal cell carcinoma
- TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features